Ebitda Изменить Дата
AstraZeneca USD 7.46B 2.3B 2026-09
Genmab DKK 401M 186M 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
GRIFOLS EUR 505M 32M 2026-09
Hikma Pharmaceutical USD 369M 84M 2024-12
Lakefront Biotherapeutics EUR -63.7M 624.2M 2026-03
Qiagen NV USD 219.78M 12.13M 2026-09
UCB EUR 1.6B 570M 2025-12